CClinicalTrials.gg
CompletedNCT05616637Updated Apr 6, 2023

Investigation of Inter-rater and Test-retest Reliability of Y Balance Test in Individuals With Pes Planus

An observational study in Flatfoot, sponsored by Istanbul Gelisim University. Completed at 1 site in Turkey. Open to participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2023-04-06.

Sponsored by Istanbul Gelisim University · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
19
Ages
18 Years to 40 Years
Sex
All
01

Study summary

Pes Planus is characterized by the descent of the medial longitudinal arch, eversion of the hindfoot, and dorsiflexion and abduction of the midfoot. Disorders in the bones of the foot, dysfunction of the tibialis posterior muscle, shortness of the Achilles tendon or weakness in the muscles may pose a risk for pes planus.

In a study in which 80 female participants aged 65 and over participated voluntarily, it was shown that 90% of the deformities seen in the foot were pes planus. In another study conducted with adults aged 18-21 years, pes planus was found with a rate of 13.6%. In a study in a group of 500 people aged 18-25 years, this rate was found to be 29%.

Since exercise, physical activity and walking for a long time will cause foot and leg pain in people with pes planus, the level of physical activity of these people may be limited. There are studies examining the relationship between pes planus and different physical parameters. It has been determined as a result of some studies that the balance, which is one of these parameters, is negatively affected by the presence of pes planus.

According to the literature, many studies have used the Y test in the evaluation of dynamic balance in individuals with pes planus. However the reliability of the Y Balance Test, which is a valid and reliable method for assessing balance in healthy individuals, has not been found in individuals with pes planus.

02

Conditions studied

  • Flatfoot

Browse trials for

Keywords

  • Postural Balance
  • Reproducibility of Results
03

In context

Flatfoot

168 studies on the registry are indexed under Flatfoot; 41 are open to participants now.

This study's enrollment of 19 is below the median of 49 across 44 observational studies indexed under Flatfoot.

Browse Flatfoot studies →

Lead sponsor

Istanbul Gelisim University is the lead sponsor of 59 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Young adults aged 18-40, with pes planus and volunteering to participate in the study will be included in the study.

Inclusion criteria

  • Volunteering to participate in the study,
  • Being between the ages of 18-40,
  • Having pes planus.

Exclusion criteria

Exclusion Criteria:

  • Having had lower extremity or spine surgery,
  • Having a neurological or rheumatic disease,
  • Having a problem with vision and hearing,
  • Having suffered a lower extremity injury in the last 1 year,
  • Presence of acute or chronic pain,
  • Regular participation in sports activities,
  • Being pregnant,
  • Ambulation with an assistive device,
  • Active participation in treatment,
  • Presence of lower extremity inequality.
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
19 participants (actual)
Patient registry
No

Groups and cohorts

  • Pes Planus

    Participants with unilateral pes planus aged 18-40 years will be included in the study.

    Diagnostic Test: Navicular Drop Test · Other: Lower Extremity Length Measurement · Other: Y Balance Test

Interventions

  • Diagnostic testNavicular Drop Test

    While participants in sitting position, the navicular tuberosity (NT) will be palpated.The most distal protruding portion of the medial NT will be marked. Participants will be asked to stand with equal weight on both feet. The new distance will be measured. The navicular drop test (NDT) results will then be obtained by comparing the measured values between the sitting and standing positions. Each measurement will be repeated three times and the average of the 3 measurements will be calculated. The expression in mm of the distance between the two marks will be considered the amount of ND. The amount of navicular fall of 10 mm or more will be interpreted as pes planus. Measurements will be made on both extremities. As a result of the measurements, if pes planus is present in a single extremity, that extremity, if it is present in both extremities, the extremity with higher NDT or if it is equal on both sides, the dominant extremity will be tested.

  • OtherLower Extremity Length Measurement

    Lower extremity length will be recorded to normalize dynamic balance test data. The person will lie in the supine position. The distance between the umbilicus and the anterior superior of the spina iliaca will be measured in cm with the help of a tape measure. If there is no asymmetry, it will be assumed that there is no rotation in the pelvis, and it will be started to measure the length of the lower extremity. If pelvic asymmetry is detected, the pelvic position will be corrected manually. Then, the most inferior point of the spina iliaca anterior superior and the most distal point of the medial malleolus will be marked and measured and recorded. Lower extremity length and data in 3 different directions will be used in cm. The purpose of using formulas is to easily provide comparisons with other studies using the same type of data. The data obtained from the formula is expressed as a percentage of the length of the limb.

  • OtherY Balance Test

    While the individual tries to balance on one bare foot at the midpoint of the assembly, the individual will also be asked to reach as far as possible with the other foot in the anterior, posteromedial and posterolateral directions, touch the tip of the toe, and then immediately return to the starting position without disturbing the balance. The test will be evaluated for 3 repetitions. Situations where the participant will be requested to repeat the test: the foot on the ground passes the reference point or the heel lifts off the ground, perturbations caused by the environment, contact of the foot with the ground, and loss of balance when returning to the starting position. 10 seconds between 3 repetitions during testing will be given. Each participant will be given the right to try 6 times before starting the test in order to eliminate the possible learning parameter. The test will be repeated 3 times in each direction and the closest distance in cm will be recorded.

06

What researchers measure

Primary outcomes

  1. Y Balance Test

    Dynamic Balance Test

    Time frame: Baseline

07

Study locations

1 site
  • Istanbul Gelisim University
    Istanbul, Avcılar 34000, Turkey
08

References and documents

Publications

  • Kim JA, Lim OB, Yi CH. Difference in static and dynamic stability between flexible flatfeet and neutral feet. Gait Posture. 2015 Feb;41(2):546-50. doi: 10.1016/j.gaitpost.2014.12.012. Epub 2014 Dec 22. PubMed 25560044 ↗
  • Kim EK, Kim JS. The effects of short foot exercises and arch support insoles on improvement in the medial longitudinal arch and dynamic balance of flexible flatfoot patients. J Phys Ther Sci. 2016 Nov;28(11):3136-3139. doi: 10.1589/jpts.28.3136. Epub 2016 Nov 29. PubMed 27942135 ↗
  • Alam F, Raza S, Moiz JA, Bhati P, Anwer S, Alghadir A. Effects of selective strengthening of tibialis posterior and stretching of iliopsoas on navicular drop, dynamic balance, and lower limb muscle activity in pronated feet: A randomized clinical trial. Phys Sportsmed. 2019 Sep;47(3):301-311. doi: 10.1080/00913847.2018.1553466. Epub 2018 Dec 5. PubMed 30517043 ↗
  • Alshehre Y, Alkhathami K, Brizzolara K, Weber M, Wang-Price S. Reliability and Validity of the Y-balance Test in Young Adults with Chronic Low Back Pain. Int J Sports Phys Ther. 2021 Jun 1;16(3):628-635. doi: 10.26603/001c.23430. PubMed 34123515 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 6, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05616637
Lead sponsor
Istanbul Gelisim University
Collaborators
Istanbul Bilgi University, Beykoz University
Responsible party
Engin Caglar (Principal Investigator, Istanbul Gelisim University) — Principal investigator
First posted
Nov 15, 2022
Start date
Dec 10, 2022
Primary completion
Feb 24, 2023
Completion
Feb 28, 2023
Last update
Apr 6, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion